Defining an Optimal Dual-Targeted CAR T-cell Therapy Approach Simultaneously Targeting BCMA and GPRC5D to Prevent BCMA Escape–Driven Relapse in Multiple Myeloma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Defining an Optimal Dual-Targeted CAR T-cell Therapy Approach Simultaneously Targeting BCMA and GPRC5D to Prevent BCMA Escape–Driven Relapse in Multiple Myeloma

Published:2020-07-06 Issue:2 Volume:1 Page:146-154
ISSN:2643-3230
Container-title:Blood Cancer Discovery
language:en
Short-container-title:Blood Cancer Discov

Author:

Fernández de Larrea Carlos^ORCID,Staehr Mette^ORCID,Lopez Andrea V.,Ng Khong Y.^ORCID,Chen Yunxin^ORCID,Godfrey William D.,Purdon Terence J.,Ponomarev Vladimir,Wendel Hans-Guido,Brentjens Renier J.,Smith Eric L.^ORCID

Funder

NIH

MSKCC

Publisher

American Association for Cancer Research (AACR)

Subject

General Medicine

Cited by 107 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Better safe than sorry: dual targeting antibodies for cancer immunotherapy;Biological Chemistry;2024-02-01

2. Update on the current and future use of CAR‐T to treat multiple myeloma;European Journal of Haematology;2023-12-15

3. Chimeric Antigen Receptor T Cells in Multiple Myeloma;Hematology/Oncology Clinics of North America;2023-12

4. Chimeric Antigen Receptor T Cells in the Treatment of Multiple Myeloma;Hematology/Oncology Clinics of North America;2023-12

5. BCMA CAR-T cells in multiple myeloma–ready for take-off?;Leukemia & Lymphoma;2023-11-24

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP